Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.
about
Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancerImaging modalities for characterising focal pancreatic lesionsDiagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancerPharmacologic and radiotherapeutic interventions for advanced pancreatic cancerDiagnostic accuracy of laparoscopy for assessing the resectability in pancreatic and periampullary cancerChemotherapy and radiotherapy for inoperable advanced pancreatic cancerChemotherapy and radiotherapy for inoperable advanced pancreatic cancerNew-onset diabetes: a potential clue to the early diagnosis of pancreatic cancerDiagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancerHow Grim is Pancreatic Cancer?Chemoradiotherapy for locally advanced pancreatic cancer patients: is it still an open question?Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancersNew insights into pancreatic cancer-induced paraneoplastic diabetesSMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.An innovative option for venous reconstruction after pancreaticoduodenectomy: the left renal veinGenome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcomePancreatic Cancer Surgical Resection Margins: Molecular Assessment by Mass Spectrometry ImagingManagement of periampullary adenocarcinoma by pancreaticoduodenectomy at a regional teaching hospital.Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimensPalliative laparoscopic hepatico- and gastrojejunostomy for advanced pancreatic cancerDoes anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer RegistryEffectiveness of plasma treatment on pancreatic cancer cells.Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary functionEvaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.Pancreatic adenocarcinoma exerts systemic effects on the peripheral blood myeloid and plasmacytoid dendritic cells: an indicator of disease severity?Analysis of paraaortic lymph node involvement in pancreatic carcinoma: a significant indication for surgery?Isoform-specific upregulation of palladin in human and murine pancreas tumors.Five-year survival following a medial pancreatectomy for an invasive ductal carcinoma from the body of the pancreas.(125)I particle implantation combined with chemoradiotherapy to treat advanced pancreatic cancer.Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cellsCCL20/CCR6 expression profile in pancreatic cancerClobenpropit enhances anti-tumor effect of gemcitabine in pancreatic cancer.Chemoradiotherapy in pancreatic carcinoma.A neoadjuvant strategy for pancreatic adenocarcinoma increases the likelihood of receiving all components of care: lessons from a single-institution database.A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma.Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma.Virulizin(R) - A review of its antineoplastic activity.High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker.Incidence and risk factors of delirium in patients post pancreaticoduodenectomy.Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.
P2860
Q24188257-8E5B25A2-D677-4E15-9F0B-C9A1FBB4BAEDQ24197582-92D8114A-CE3A-4177-8CAF-8657DA30045DQ24202308-AEC4483B-A7DC-478C-B5D9-F0C57D7AAADDQ24202423-056CBD04-75F3-4E59-8486-865C8E6B2EBEQ24236365-F8B6CCFC-1AD5-4BC3-A213-90FF63145CD5Q24240739-514DB570-736E-4110-9CDF-F4310D027CCDQ24245085-BD7E1926-69EE-4227-9B38-1C10E757A8D9Q24656132-E245BC71-4BD4-4D0D-BC44-D46550542569Q26470971-B4B767BF-A4CB-49DE-B438-739044A6FEB2Q26740598-C1E39F17-59C0-4482-B71F-B630D1D1C56FQ26746031-C2DAE518-4419-41C6-8520-FAD8437C8133Q27004276-82FF8C33-6397-4ABB-B2E7-8E8950422B1BQ27687766-A3717512-C917-4DB3-8283-22174F5019FDQ27851475-FB996D08-6256-48E8-A849-11F7AFC12D59Q28222330-47C695C9-50D9-45C1-BF13-0C8B82374BCBQ28283932-73B7870E-1A90-4B2F-8E1A-459DE9B26059Q28554008-FFD9C8BD-08EF-4876-AC8A-298CF62FCD23Q30278871-85AB283A-8BCF-41E1-AB0C-23B06D2E77B4Q30416415-ABC653EB-4303-47BA-9852-7D7D5AACF110Q30476255-729726F1-9D12-4DE5-BCE8-CA149FA5A989Q30982758-7013AF5A-F677-4C00-BBCF-487D5403347DQ33466056-E8A77071-5500-498C-9C33-4FE4AF810754Q33487496-A72A753D-5979-41A3-8328-EBCADCAFA202Q33489063-7B0F47BC-7FA4-4327-9B6A-F8F109CC2948Q33538894-CFDB5788-F10B-4F8B-8B34-F9827A807842Q33544933-D4D09543-AFC8-4CBC-934B-5E56A53F2B0DQ33570447-61DE7139-CA9E-40B1-9FD6-F724DB6793C7Q33788531-6A5D3217-65AC-41F5-A365-9B6270D84ABBQ33792260-47E8102F-CB8C-4BBF-BE86-4263E054E6BEQ33792279-21B8E29C-EEE4-4C81-B483-829CCF65A357Q33878671-DB5A5AC7-2316-4CC7-B5B9-5D083CB537A0Q33887021-CD8C90F5-56DD-4DA8-B729-3B34711F4730Q33914136-C915EF1C-F655-40CF-A32B-25130DAF52B3Q33928176-CC8E28AD-50B7-43B9-B102-3D96FDEE2F19Q33992146-9770556F-63AA-4726-A181-067C91CDABB8Q34045939-4DECCABD-81A8-4F18-B6FE-742039D6D11CQ34119525-2A0766BD-B7F2-43B2-8F6D-D4645142B790Q34126942-F1FC1AF7-47D3-4CC7-8F7D-AA13A9028EB1Q34156836-35813306-F26E-4751-A558-26893096D3E0Q34183257-0E61F40D-26A4-4BD2-BAAE-22671681FC3C
P2860
Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.
description
1996 nî lūn-bûn
@nan
1996 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մարտին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Long-term survival after curat ...... analysis of 5-year survivors.
@ast
Long-term survival after curat ...... analysis of 5-year survivors.
@en
Long-term survival after curat ...... analysis of 5-year survivors.
@nl
type
label
Long-term survival after curat ...... analysis of 5-year survivors.
@ast
Long-term survival after curat ...... analysis of 5-year survivors.
@en
Long-term survival after curat ...... analysis of 5-year survivors.
@nl
prefLabel
Long-term survival after curat ...... analysis of 5-year survivors.
@ast
Long-term survival after curat ...... analysis of 5-year survivors.
@en
Long-term survival after curat ...... analysis of 5-year survivors.
@nl
P2093
P1433
P1476
Long-term survival after curat ...... analysis of 5-year survivors.
@en
P2093
Brennan MF
Klimstra DS
P304
P356
10.1097/00000658-199603000-00007
P407
P577
1996-03-01T00:00:00Z